Laurent Pharmaceuticals Inc.   Report issue

For profit Phase 3
Founded: Montreal Canada (2014)

Organization Overview

First Clinical Trial
2018
NCT03265288
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Laurent Pharmaceuticals Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

fenretinide (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1